Clicky

Certified Solvency ii Training for the countries of the EEA
Certified Solvency ii Training for countries outside the EEA
Own Risk and Solvency Assessment (ORSA)
Solvency and Financial Condition Report
 
 
Member Benefits                                               ►  Certified Solvency ii Training
   ► How to Become a Member                                ► Order Your Certificate Of Membership  
Reading Room                                                   ► Contact Us

Consultation Paper No. 49 - CEIOPS-CP-49/09, 2 July 2009
Draft CEIOPS Advice for Level 2 Implementing Measures on Solvency II:
Standard formula SCR - Article 109 c, Life underwriting risk
 
3.4. Disability-morbidity risk

3.4.1. Explanatory text
Introduction


3.53. Morbidity or disability risk is associated with all types of insurance compensating or reimbursing losses (e.g. loss of income) caused by illness, accident or disability (income insurance), or medical expenses due to illness, accident or disability (medical insurance).

3.54. It is applicable for (re)insurance obligations contingent on a definition of disability.


However CEIOPS
expects that the majority of (re)insurance obligations for which disability-morbidity risk is applicable will be covered by the health module rather than by the life underwriting module.

This sub-module of the life underwriting risk module is therefore likely to be applicable only in cases where contracts cannot be unbundled.

3.55. The capital charge for morbidity or disability risk is intended to reflect the uncertainty in morbidity and disability parameters as a result of changes in the level, trend and volatility of disability, sickness and morbidity rates and capture the risk that more policyholders than anticipated are diagnosed with the diseases covered or are or unable to work as a result of sickness or disability during the policy term.

3.56. The (re)insurance obligations may be structured such that, upon the diagnosis of a disease or the policyholder being unable to work as a result of sickness or disability, recurring payments are triggered.

These payments may continue until the expiry of some defined period of time or until either the recovery or death of the policyholder.

In the latter case, the (re)insurance undertaking is also exposed to the risk that the policyholders receives the payments for longer than anticipated i.e. that claim termination rates are lower than anticipated (recovery risk).


3.57. Morbidity and disability risk is normally captured by increasing the claim inception rate either by a fixed amount or by a proportion of the base inception rates and, where applicable, reducing the claim termination rates.

The calibration (of the increase) should capture the impact of each of the above factors (level, trend and volatility).

Morbidity and disability risk in QIS4

3.58. The QIS4 approach to the SCR standard formula included a morbidity and disability risk sub-module in the life underwriting risk module (section TS.XI.B of the QIS4 Technical Specifications (MARKT/2505/08)).

The calculation of the capital requirement for morbidity and disability risk was a scenario based stress. The scenario tested was an increase of 35% to “disability rates” for the first year followed by a 25% increase in “disability rates” for all subsequent years.

3.59. An alternative scenario was also proposed by the UK under which the capital charges for critical illness, income protection and long term care obligations were calculated separately and there was an additional capital charge in respect of recovery risk.

3.60. There were a number of comments from QIS4 participants on the general methodology of the morbidity and disability stress:

• One respondent argued that recovery rates should be taken into account.

• There was some confusion over the treatment of disability in terms of catastrophe risk.

• Support for the UK alternative approach was noted by one Member State.


3.61. With respect to the calibration of the morbidity and disability stress, some (re)insurance undertakings commented that the calibration was too strong.

Calculation of the capital requirement


3.62. As described above, there are two aspects to morbidity/disability risk:

• The risk that the number of claims are greater than anticipated

• The risk that the duration of the claim is higher than anticipated


The second risk is only applicable for (re)insurance obligations where benefits consist of recurring payments which continue until either the recovery or death of the policyholder.

3.63. Therefore the capital requirement should be calculated as:

• The change in net asset value (assets minus liabilities) following an increase of x1% in morbidity/disability inception rates for the first year followed by an increase of x2% in morbidity/disability inception rates for all subsequent years.

• Plus, where applicable, the change in net asset value (assets minus liabilities) following a permanent decrease of y% in morbidity/disability recovery rates

Calibration of morbidity and disability stress

3.64. The basis for the QIS4 calibration of the morbidity-disability risk stress is described in the CEIOPS paper “QIS3 Calibration of underwriting risk, market risk and MCR”.

This paper is available from the CEIOPS website.

3.65. Subsequent to QIS4, an investigation by the Swedish FSA indicated that an increase of 50% in morbidity/disability inception rates for the first year would be more appropriate.

3.66. This investigation also suggested that the appropriate calibration of the decrease in morbidity/disability recovery rates was 20%.

3.67. The results of the investigation by the Swedish FSA are explained further in Appendix A.

3.68. In addition, the UK Actuarial Profession Healthcare Reserving Working Party has undertaken a survey which investigated the levels of 1 in 200 year morbidity stresses used by the major UK life insurance firms.

3.69. The range of stress used by the major UK life insurers for income protection business averaged 27% for inception rates and 15% for termination rates.

For critical illness, morbidity margins, intended to represent a 99.5% confidence over 1 year, averaged around 40%.

3.70. Furthermore, on average, the average morbidity margins for statutory reserving for critical illness and income protection (both inceptions and terminations) were about 20%.

The margins in a statutory reserving basis are partly to allow for adverse deviations of the inception and termination rates used in the pricing.

As such, a 1 in 200 stress should be at least greater than these margins as these margins are not normally set at the same level as a 1 in 200 year scenario.

3.71. Looking at the results of this survey in conjunction with the results of the investigation by the Swedish FSA, we would propose the following calibration of the disability-morbidity stress:

• The change in net asset value (assets minus liabilities) following an increase of 50% in morbidity/disability inception rates for the first year followed by an increase of 25% in morbidity/disability inception rates for all subsequent years.

• Plus, where applicable, the change in net asset value (assets minus liabilities) following a permanent decrease of 20% in morbidity/disability recovery rates.

This should be applied together with the above increase in inception rates i.e. it is a combined stress.

3.4.2. CEIOPS’ advice
Morbidity-disability risk


3.72. The morbidity-disability risk sub-module is applicable for (re)insurance obligations contingent on a definition of disability.

3.73. The calculation of the capital requirement for disability risk shall be a scenario based stress.

3.74. The capital requirement shall be calculated as the change in net asset value (assets minus liabilities) following:

• An increase of 50% in morbidity/disability inception rates for the first year followed by an increase of 25% in morbidity/disability inception rates for all subsequent years.

• Plus, where applicable, a permanent decrease of 20% in morbidity/disability recovery rates.
 

 
Life Underwriting Risk:
 
Introduction to Solvency ii Life Underwriting Risk
 
Solvency ii Mortality Risk
 
Solvency ii Longevity Risk
 
Solvency ii Disability Morbidity Risk
 
Solvency ii Life Expense Risk
 
Solvency ii Life Revision Risk
 
Solvency ii Lapse Risk
 
Solvency ii Life Catastrophe Risk